BENIGN PROSTATIC HYPERPLASIA

This adverse event was reported 5169 times

These drugs are most commonly taken by patients reporting BENIGN PROSTATIC HYPERPLASIA:

# Drug Count
0 ASPIRIN 697
1 ASPIRIN 325 MG 679
2 ASPIRIN 81 MG 679
3 TADALAFIL 673
4 FINASTERIDE 463
5 PANTOPRAZOLE 454
6 PREDNISONE 445
7 ALBUTEROL SULFATE 409
8 FUROSEMIDE 407
9 TIOTROPIUM BROMIDE 371
See all common drugs associated with BENIGN PROSTATIC HYPERPLASIA

BENIGN PROSTATIC HYPERPLASIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AMMONIUM CHLORIDE 47 0.1880
1 CHLORAMPHENICOL SODIUM SUCCINATE 5 0.1515
2 METHACHOLINE CHLORIDE 4 0.0571
3 ASIAN GINSENG 18 0.0427
4 DOBUTAMINE HYDROCHLORIDE 38 0.0293
5 ALLOPURINOL SODIUM 15 0.0266
6 HEPARIN SODIUM AND DEXTROSE 19 0.0263
7 EFINACONAZOLE 45 0.0229
8 NATAMYCIN 9 0.0220
9 ADALIMUMAB-AACF 7 0.0209
See all drugs enriched for association with BENIGN PROSTATIC HYPERPLASIA

BENIGN PROSTATIC HYPERPLASIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 45 0.0654
1 Polyene Antimicrobial [EPC] 9 0.0220
2 Osmotic Diuretic [EPC] 47 0.0090
3 Provitamin D2 Compound [EPC] 237 0.0080
4 Vitamin K [EPC] 61 0.0071
5 Guanylate Cyclase-C Agonist [EPC] 14 0.0067
6 Phosphodiesterase 5 Inhibitor [EPC] 686 0.0051
7 5-alpha Reductase Inhibitor [EPC] 517 0.0050
8 Stimulant Laxative [EPC] 62 0.0043
9 Vitamin D3 Analog [EPC] 73 0.0036
See all drug classes enriched for association with BENIGN PROSTATIC HYPERPLASIA